WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Synaptic Systems Antibody Company
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, January 23, 2008, 28(4):862-867; doi:10.1523/JNEUROSCI.3072-08.2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spires-Jones, T. L.
Right arrow Articles by Hyman, B. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spires-Jones, T. L.
Right arrow Articles by Hyman, B. T.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene

 Previous Article  |  Next Article 

Brief Communications
In Vivo Imaging Reveals Dissociation between Caspase Activation and Acute Neuronal Death in Tangle-Bearing Neurons

Tara L. Spires-Jones,1 Alix de Calignon,1 Toshifumi Matsui,1 Cindy Zehr,3 Rose Pitstick,4 Hai-Yan Wu,1 Jennifer D. Osetek,1 Phillip B. Jones,1,2 Brian J. Bacskai,1 Mel B. Feany,5 George A. Carlson,4 Karen H. Ashe,6 Jada Lewis,3 and Bradley T. Hyman1

1MassGeneral Institute for Neurodegenerative Disease and 2Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, 3Neurogenetics, Neurotransgenics and Neuropathology Laboratories, Mayo Clinic, Jacksonville, Florida 32224, 4McLaughlin Research Institute, Great Falls, Montana 59405, 5Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, and 6Department of Neurology, University of Minnesota Medical School, Minneapolis, Minnesota 55455

Correspondence should be addressed to Bradley T. Hyman, MassGeneral Institute for Neurodegenerative Disease, 114 16th Street, Charlestown, MA 02129. Email: bhyman{at}partners.org

Accumulation of neurofibrillary tangles (NFTs) in Alzheimer's disease correlates with neuronal loss and cognitive decline, but the precise relationship between NFTs and neuronal death and downstream mechanisms of cell death remain unclear. Caspase cleaved products accumulate in tangles, implying that tangles may contribute to apoptotic neuronal death. To test this hypothesis, we developed methods using multiphoton imaging to detect both neurofibrillary pathology and caspase activation in the living mouse brain. We examined rTg4510 mice, a reversible mouse model of tauopathy that develops tangles and neuronal loss. Only a small percentage of imaged neurons were caspase activity positive, but the vast majority of the cells with active caspases contained NFTs. We next tested the hypothesis that caspase activation led to acute, apoptotic neuronal death. Caspase positive cell bodies did not degenerate over hours of imaging, despite the presence of activated executioner caspases. Suppression of the transgene, which stops ongoing death, did not suppress caspase activity. Finally, histochemical assessments revealed evidence of caspase-cleaved tau, but no TUNEL (terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling) positive or apoptotic nuclei. With the novel technique of observing NFTs and caspase activation in the living brain, we demonstrate that aggregated tau in neurons can be associated with caspase activation, but that caspase activation is not sufficient to cause acute neuronal death in this model.

Key words: Alzheimer's; neurofibrillary tangle; caspase; apoptosis; multiphoton imaging; tauopathy


Received July 6, 2007; revised Oct. 18, 2007; accepted Nov. 16, 2007.

Correspondence should be addressed to Bradley T. Hyman, MassGeneral Institute for Neurodegenerative Disease, 114 16th Street, Charlestown, MA 02129. Email: bhyman{at}partners.org






-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-